Skip to Content

Proposed Rule

Additions and Modifications to the List of Drug Products That Have Been Withdrawn or Removed From the Market for Reasons of Safety or Effectiveness; Correction

Document Details

Information about this document as published in the Federal Register.

Enhanced Content

Relevant information about this document from Regulations.gov provides additional context. This information is not part of the official Federal Register document.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble Start Printed Page 68395

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Proposed rule; withdrawal of previous proposed rule; correction.

SUMMARY:

The Food and Drug Administration (FDA) is correcting a document entitled “Additions and Modifications to the List of Drug Products That Have Been Withdrawn or Removed From the Market for Reasons of Safety or Effectiveness” that appeared in the Federal Register of July 2, 2014. The document proposed amending FDA's regulations to revise the list of drug products that may not be compounded under the exemptions provided by the Federal Food, Drug, and Cosmetic Act because the drug products have been withdrawn or removed from the market after the drug products or components of such drug products were found to be unsafe or not effective. The document also withdrew the previous proposed rule regarding additions to this list (see the Federal Register of January 4, 2000). The document was published with an incorrect RIN number. This document corrects the error.

DATES:

The proposed rule published July 2, 2014 (79 FR 37687) is corrected as of November 17, 2014.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Edisa Gozun, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 51, Rm. 5199, Silver Spring, MD 20993-0002, 301-796-3110.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

In FR Doc. 2014-15371, appearing on page 37687 in the Federal Register of July 2, 2014 (79 FR 37687), FDA is making the following correction:

1. On page 37687, in the first column, the RIN number heading is corrected to read “RIN 0910-AH08”.

2. On page 37687, in the second column, the RIN number under the ADDRESSES heading is corrected to read “RIN 0910-AH08”.

3. On page 37687, in the second column, the RIN number under the Instructions sub-heading is corrected to read “RIN 0910-AH08”.

Start Signature

Dated: November 10, 2014.

Leslie Kux,

Assistant Commissioner for Policy.

End Signature End Supplemental Information

[FR Doc. 2014-27038 Filed 11-14-14; 8:45 am]

BILLING CODE 4164-01-P